surmount-1 tirzepatide weight loss results for the Maintenance of Body Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT‐MAINTAIN - Horn - 2025 - Obesity SURMOUNT-1: Adults achieve weight loss

If you have been at 10mg for fewer than eight weeks, you may not have reached steady-state plateau yet

Both imitate a hormone called glucagon-like peptide-1, known as GLP-1

In the battle against the global obesity epidemic, new treatments are continually emerging

Call your doctor right away if you have any of the following: Severe stomach pain (pancreatitis): Stop taking tirzepatide and call your healthcare provider immediately if you have severe pain in your stomach area that will not go away, with or without vomiting, or pain that spreads to your back

Patients switching from failed insurance pathways to PlexusDx typically report faster dose escalation, fewer interruptions in treatment continuity, and more predictable monthly budgeting

Each patient may lose weight at a different rate and experience different side effects